NX Stock Analysis: Quanex Building Products | NYSE
Building Products & Equipment | NYSE, USA | Market Cap: 866m USD | 12M Return: 31.6% | US7476191041 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 7.64M
EPS Trend: -90.9%
Qual. Beats: 0
Rev. Trend: 93.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Quanex Building Products Corporation (NYSE: NX) is a Houston-based manufacturer and distributor of components serving OEMs in the global building products industry. Founded in 1927, the company produces a diverse range of items including insulating glass spacers, extruded vinyl profiles, window and door screens, seals, hardware, solar panel sealants, vinyl decking, and conservatory roof components. Its products are sold through a mix of direct sales, independent sales agents, distributors, and sales representatives across the United States, Europe, Canada, Asia, and other international markets.
Operating within the Industrials sector and the Building Products sub-industry, Quanex is classified as a small-cap stock with a market capitalization of approximately $905 million and has been publicly traded since 1987. The companys product portfolio spans both fenestration components (window and door parts) and adjacent building solutions, positioning it across multiple segments of the residential and commercial construction value chain.
- Tyman acquisition expands international footprint and revenue base
- Housing starts and remodeling demand drive component volumes
- Energy efficiency codes boost demand for insulating glass spacers
| Net Income: 45.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 3.22 > 1.0 |
| NWC/Revenue: 17.84% < 20% (prev 17.32%; Δ 0.52% < -1%) |
| CFO/TA 0.07 > 3% & CFO 145.5m > Net Income 45.4m |
| Net Debt (959.5m) to EBITDA (223.1m): 4.30 < 3 |
| Current Ratio: 2.23 > 1.5 & < 3 |
| Outstanding Shares: last quarter (45.6m) vs 12m ago -1.61% < -2% |
| Gross Margin: 22.73% > 18% (prev 26.02%; Δ -3.29% > 0.5%) |
| Asset Turnover: 94.54% > 50% (prev 93.27%; Δ 1.27% > 0%) |
| Interest Coverage Ratio: 2.50 > 6 (EBIT TTM 124.4m / Interest Expense TTM 49.9m) |
| A: 0.17 (Total Current Assets 602.3m - Total Current Liabilities 269.9m) / Total Assets 1.97b |
| B: 0.09 (Retained Earnings 179.5m / Total Assets 1.97b) |
| C: 0.06 (EBIT TTM 124.4m / Avg Total Assets 1.97b) |
| D: 0.61 (Book Value of Equity 745.4m / Total Liabilities 1.22b) |
| Altman-Z'' = 2.47 = A |
| DSRI: 1.08 (Receivables 220.4m/201.8m, Revenue 1.86b/1.84b) |
| GMI: 1.14 (GM 26.02% / 22.73%) |
| AQI: 0.96 (AQ_t 0.41 / AQ_t-1 0.42) |
| SGI: 1.01 (Revenue 1.86b / 1.84b) |
| TATA: -0.05 (NI 45.4m - CFO 145.5m) / TA 1.97b) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of October 19, 2026, the stock is trading at USD 18.89 with a total of 366,506 shares traded. Over the past week, the price has changed by +3.28%, over one month by -8.03%, over three months by +4.36% and over the past year by +31.56%.
Current recommended Stop Loss: 17.70 (which is 6.3% or 1.4 ATR below the current price).
Quanex Building Products has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy NX.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 26 | 37.6% |
P/E Trailing = 19.4742
P/E Forward = 10.02
P/S = 0.4646
P/B = 1.2191
P/EG = 0.7154
Revenue TTM = 1.86b USD
EBIT TTM = 124.4m USD
EBITDA TTM = 223.1m USD
Long Term Debt = 636.8m USD (from longTermDebt, last quarter)
Short Term Debt = 45.4m USD (from shortTermDebt, last quarter)
Debt = 1.02b USD (from shortLongTermDebtTotal, last quarter) + Leases 179.1m
Net Debt = 959.5m USD (calculated: Debt 1.02b - CCE 62.1m)
Enterprise Value = 1.83b USD (865.7m + Debt 1.02b - CCE 62.1m)
Interest Coverage Ratio = 2.50 (Ebit TTM 124.4m / Interest Expense TTM 49.9m)
EV/FCF = 20.10x (Enterprise Value 1.83b / FCF TTM 90.8m)
FCF Yield = 4.98% (FCF TTM 90.8m / Enterprise Value 1.83b)
FCF Margin = 4.87% (FCF TTM 90.8m / Revenue TTM 1.86b)
Net Margin = 2.43% (Net Income TTM 45.4m / Revenue TTM 1.86b)
Gross Margin = 22.73% ((Revenue TTM 1.86b - Cost of Revenue TTM 1.44b) / Revenue TTM)
Gross Margin QoQ = 23.62% (prev 20.14%)
Tobins Q-Ratio = 0.93 (Enterprise Value 1.83b / Total Assets 1.97b)
Interest Expense / Debt = 4.88% (Interest Expense 49.9m / Debt 1.02b)
Taxrate = 37.32% (27.0m / 72.4m)
NOPAT = 78.0m (EBIT 124.4m * (1 - 37.32%))
Current Ratio = 2.23 (Total Current Assets 602.3m / Total Current Liabilities 269.9m)
Debt / Equity = 1.37 (Debt 1.02b / totalStockholderEquity, last quarter 745.4m)
Debt / EBITDA = 4.30 (Net Debt 959.5m / EBITDA 223.1m)
Debt / FCF = 10.57 (Net Debt 959.5m / FCF TTM 90.8m)
Total Stockholder Equity = 732.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.30% (Net Income 45.4m / Total Assets 1.97b)
RoE = 6.19% (Net Income TTM 45.4m / Total Stockholder Equity 732.3m)
RoCE = 9.09% (EBIT 124.4m / Capital Employed (Equity 732.3m + L.T.Debt 636.8m))
RoIC = 4.64% (NOPAT 78.0m / Invested Capital 1.68b)
WACC = 6.96% (E(865.7m)/V(1.89b) * Re(11.57%) + D(1.02b)/V(1.89b) * Rd(4.88%) * (1-Tc(0.37)))
Discount Rate = 11.57% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 62.47 | Cagr: 15.35%
[DCF] Terminal Value 77.97% ; FCFF base≈65.5m ; Y1≈75.1m ; Y5≈110.5m
[DCF] Fair Price = 15.34 (EV 1.66b - Net Debt 959.5m = Equity 702.8m / Shares 45.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -90.95 | EPS CAGR: -14.09% | SUE: 0.82 | # QB: 0
Revenue Correlation: 93.64 | Revenue CAGR: 27.97% | SUE: 0.55 | # QB: 0
EPS current Quarter (2027-01-31): EPS=-0.03 | Chg30d=N/A | Revisions=-25% | Analysts=4
EPS current Year (2026-10-31): EPS=1.82 | Chg30d=+10.15% | Revisions=+50% | GrowthEPS=-21.0% | GrowthRev=+2.0%
EPS next Year (2027-10-31): EPS=1.97 | Chg30d=-6.18% | Revisions=-40% | GrowthEPS=+8.5% | GrowthRev=+0.5%
[Analyst] Revisions Ratio: +0% (up=3, down=3)